Published on: October 3, 2024

KARNATAKA RARE BLOOD DONOR PROGRAMME

KARNATAKA RARE BLOOD DONOR PROGRAMME

 NEWS –  Karnataka government launches  rare blood donor programme

HIGHLIGHTS

  • The programme aims to support patients with rare blood groups by creating a database of voluntary donors.
  • Launched by Rotary Bangalore TTK Blood Centre’s Bangalore Medical Services Trust (BMST) in collaboration with Karnataka State Blood Transfusion Council.
  • Inaugurated by Health Minister Dinesh Gundu Rao on National Voluntary Blood Donation Day, October 1.

Key Features of the Programme

  1. Rare Blood Donor Registry:
    • Database of voluntary donors with rare blood groups.
    • Repository of frozen red cell units of rare blood types.
  2. Collaborations and Support:
    • Technical expertise from National Institute of Immunohematology (ICMR Mumbai), New York Blood Center (U.S.), and International Society of Blood Transfusion (ISBT, Amsterdam).
    • Training and awareness programs for blood centres in Karnataka.
  3. Blood Group Testing:
    • Extended testing by serology and molecular techniques.
    • Identifying rare blood types among patients and their families.

Progress So Far

  • Registry Development:
    • 500 individuals tested, 60 donors enrolled.
    • Data shared with the International Rare Donor Panel.
  • Unique Contribution:
    • One of only two centres in India with a rare blood donor registry (ICMR Mumbai being the other).

Understanding Rare Blood Groups

  1. Blood Group Systems:
    • 45 blood group systems identified; ABO and Rh (Rhesus factor) are the most common.
    • Other blood groups are rarer, found in less than 1 in 1,000 or 1 in 10,000 people.
  2. Examples of Rare Blood Groups:
    • Bombay (Oh) phenotype, Rh-D-/-D-, In(a+b-), Co(a-b-), CdE/CdE, Mg.
    • Weaker variants of A, B, O, and Rh antigens.

Clinical Significance

  • Rare blood types are crucial for patients with conditions like thalassemia, cancer, or those needing multiple transfusions.
  • Precisely matched blood is needed for such patients to avoid adverse reactions during transfusions.